PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 47 filers reported holding PDS BIOTECHNOLOGY CORP in Q2 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $207,797 | +16.7% | 41,148 | +16.2% | 0.00% | 0.0% |
| Q2 2023 | $178,102 | +495.9% | 35,408 | +628.6% | 0.00% | – |
| Q1 2023 | $29,889 | -76.7% | 4,860 | -49.9% | 0.00% | – |
| Q4 2022 | $128,027 | – | 9,699 | +9599.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 100 | -75.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 400 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 400 | +33.3% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 300 | +50.0% | 0.00% | – |
| Q3 2021 | $3,000 | – | 200 | +700.0% | 0.00% | – |
| Q1 2021 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INSPIRION WEALTH ADVISORS, LLC | 330,874 | $1,670,914 | 0.33% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $2,020,000 | 0.28% |
| Iron Gate Global Advisors LLC | 75,016 | $377,330 | 0.08% |
| Nebula Research & Development LLC | 25,708 | $129,825 | 0.07% |
| Corton Capital Inc. | 22,091 | $111,560 | 0.06% |
| Sofinnova Investments, Inc. | 142,635 | $720,307 | 0.04% |
| LAZARI CAPITAL MANAGEMENT, INC. | 11,000 | $55,550 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,369 | $123,063 | 0.02% |
| WINTON GROUP Ltd | 21,256 | $107,343 | 0.01% |
| Truvestments Capital LLC | 1,372 | $6,929 | 0.00% |